Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
In mice, both chronic and acute alcohol decreased NTS1 and NTS2 in the NAc and midbrain (Campbell and Gene Erwin, 1993)
Bottom line: In humans, the biggest driver of "Wegovy muscle loss risk" is usually the weight-loss context (low protein + low strength training), not a proven direct "muscle-toxic" effect
It justified bringing Wegovy to market by treating obesity as a chronic, life-threatening disease rather than the self-inflicted, stigma-inducing result of unhealthy habits
Patients on Tirzepatide 15 mg weekly lost an average of 20.9% or 48.6 lb of their body weight after 72 weeks in the Zepbound Study 1 (NCT04184622) compared to placebo patients who lost an average of 3.1% or 7.2 lb
US$ 28.01
US$ 27.83
US$ 22.07
